Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2015
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
A07DA06
|
| gptkbp:CASNumber |
gptkb:864821-90-9
|
| gptkbp:chemicalFormula |
C32H35N5O5S
|
| gptkbp:contraindication |
alcoholism
history of pancreatitis biliary duct obstruction patients without a gallbladder |
| gptkbp:drugClass |
opioid receptor modulator
|
| gptkbp:genericName |
gptkb:eluxadoline
|
| https://www.w3.org/2000/01/rdf-schema#label |
Viberzi
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Allergan
|
| gptkbp:mechanismOfAction |
mu-opioid receptor agonist
delta-opioid receptor antagonist kappa-opioid receptor agonist |
| gptkbp:pregnancyCategory |
Not assigned (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
abdominal pain constipation pancreatitis |
| gptkbp:usedFor |
irritable bowel syndrome with diarrhea
|
| gptkbp:bfsParent |
gptkb:eluxadoline
|
| gptkbp:bfsLayer |
8
|